Siblings Conference Papers/Meeting Abstract [5/7] Collection Statistics Item counts issued in 3 years:2(7.41%) Items With Fulltext:27(100.00%) Download counts of the item Download times greater than 0:27(100.00%) Download times greater than 100:26(96.30%) Total Bitstream Download Counts:12037(85.86%) Last Update: 2024-12-01 03:33 Top Upload Loading... Top Download Loading... Recent Submissions Oncogenic ASPM is a regulatory hub ... ASPM activates Hedgehog and Wnt sig... A Novel Invadopodia-Specific Marker... A novel invadopodia-specific marker... A multi-mode Wnt- and stemness-regu... A multi-mode Wnt- and stemness-regu... Dishevelled 1-regulated superpotent... A multicenter, phase I/II trial of ... Histone demethylase KDM4C stimulate... The differential distributions of A...

Jump to a point in the index: (Choose year) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (Choose month) January February March April May June July August September October November December Or type in a year:

Ordering With Most Recent First Show Oldest First

Showing items 1-25 of 27. (2 Page(s) Totally) 1 2 > >> View [10|25|50] records per page

Date	Title	Relation
2023-09-15	Oncogenic ASPM is a regulatory hub of developmental and stemness signaling in cancers	Cancer Research. 2023 Sep 15;83(18):2993-3000.
2023-03	ASPM activates Hedgehog and Wnt signaling to promote small cell lung cancer stemness and progression	Cancer Research. 2023 Mar 15;83(6):830-844.
2021-06-22	A Novel Invadopodia-Specific Marker for Invasive and Pro-Metastatic Cancer Stem Cells [Erratum:Frontiers in Oncology. 2021 May 31;11:Article number 638311.]	Frontiers in Oncology. 2021 Jun 22;11:Article number 718849.
2021-05-31	A novel invadopodia-specific marker for invasive and pro-metastatic cancer stem cells	Frontiers in Oncology. 2021 May 31;11:Article number 638311.
2021-05	A multi-mode Wnt- and stemness-regulatory module dictated by FOXM1 and ASPM isoform I in gastric cancer	Gastric Cancer. 2021 May;24(3):624-639.
2021-05	A multi-mode Wnt- and stemness-regulatory module dictated by FOXM1 and ASPM isoform I in gastric cancer[Erratum:Gastric Cancer. 2021 May;24(3):624-639.]	Gastric Cancer. 2021 May;24(3):640-641.
2020-03-10	Dishevelled 1-regulated superpotent cancer stem cells mediate wnt heterogeneity and tumor progression in hepatocellular carcinoma	Stem Cell Reports. 2020 Mar 10;14(3):462-477.
2020-02	The multifaceted role of mesenchymal stem cells in cancer	Seminars in Cancer Biology. 2020 Feb;60:225-237.
2020-01	A multicenter, phase I/II trial of biweekly S-1, leucovorin, oxaliplatin and gemcitabine in metastatic pancreatic adenocarcinoma–TCOG T1211 study	European Journal of Cancer. 2020 Jan;124:123-130.
2019-12	The differential distributions of ASPM isoforms and their roles in Wnt signaling, cell cycle progression, and pancreatic cancer prognosis	Journal of Pathology. 2019 Dec;249(4):498-508.
2019-11-13	Histone demethylase KDM4C stimulates the proliferation of prostate cancer cells via activation of AKT and c-Myc	Cancers. 2019 Nov 13;11(11):Article number 1785.
2019-07	Targeting the interplay between cancer fibroblasts, mesenchymal stem cells, and cancer stem cells in desmoplastic cancers	Frontiers in Oncology. 2019 Jul;9:Article number 688.
2019-05-17	Next viable routes to targeting pancreatic cancer stemness: Learning from clinical setbacks	Journal of Clinical Medicine. 2019 May 17;8(5):Article number 702.
2019-02	ASPM promotes prostate cancer stemness and progression by augmenting Wnt-Dvl-3-beta-catenin signaling	Oncogene. 2019 Feb;38(8):1340-1353.
2019-02	ASPM promotes prostate cancer stemness and progression by augmenting Wnt-Dvl-3-beta-catenin signaling [Erratum: Oncogene. 2019 Feb;38(8):1340-1353.]	Oncogene. 2019 Feb;38(8):1354.
2017-11	Stress stimuli induce cancer-stemness gene expression via Sp1 activation leading to therapeutic resistance in glioblastoma	Biochemical and Biophysical Research Communications. 2017 Nov;493(1):14-19.
2017-05	Metronomic chemotherapy: Direct targeting of cancer cells after all?	Trends in Cancer. 2017 May;3(5):319-325.
2016-12	Metronomic chemotherapy prevents therapy-induced stromal activation and induction of tumor-initiating cells	Journal of Experimental Medicine. 2016 Dec;213 (13):2967-2988.
2015-09	Targeting chemotherapy-induced PTX3 in tumor stroma to prevent the progression of drug-resistant cancers	Oncotarget. 2015 Sep;6(27):23987-24001.
2014-07	Cancer/stroma interplay via cyclooxygenase-2 and indoleamine 2,3-dioxygenase promotes breast cancer progression	Breast Cancer Research. 2014 Jul;16(4):Article number 410.
2013-11	A gene expression signature of epithelial tubulogenesis and a role for ASPM in pancreatic tumor progression	Gastroenterology. 2013 Nov;145(5):1110-1120.
2013-06-13	Cholestane-3beta, 5alpha, 6beta-triol suppresses proliferation, migration, and invasion of human prostate cancer cells	PLoS ONE. 2013 Jun 13;8(6):Article number e65734.
2013-05	Complete microscale profiling of tumor microangiogenesis: A microradiological methodology reveals fundamental aspects of tumor angiogenesis and yields an array of quantitative parameters for its characterization	Biotechnology Advances. 2013 May;31(3):396-401.
2013-02	Molecular profiling of prostatic acinar morphogenesis identifies PDCD4 and KLF6 as tissue architecture-specific prognostic markers in prostate cancer	American Journal of Pathology. 2013 Feb;182(2):363-374.
2012-08-14	Control of cyclooxygenase-2 expression and tumorigenesis by endogenous 5-methoxytryptophan	Proceedings of the National Academy of Sciences of the United States of America. 2012 Aug 14;109(33):13231-13236.

Showing items 1-25 of 27. (2 Page(s) Totally) 1 2 > >> View [10|25|50] records per page